Back to News
Market Impact: 0.12
Linkage Global's ClickClack Chief Scientist Recognized for Coma Awakening Research as Company and Hospital Partner Launch Second-Stage Clinical Research
Source: globenewswire.com
Healthcare & BiotechMedical & Biotech

A two-year observational study of 407 deep coma patients found 32 awakenings (7.86%). Linkage Global and its hospital partner are now starting second-stage clinical research to study cognitive impairment and sleep disorders. The recognition and next-stage work are mildly positive, but this is early-stage research with limited immediate market implications.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
More News
- Schott Pharma drops after Deutsche Bank downgrades on demanding valuation
- William Blair downgrades Alignment Healthcare stock rating on cost pressures
- Baird upgrades Humana stock rating on margin recovery outlook
- Why is argenx stock rallying today?
- We’re still figuring out the side effects of GLP-1 weight-loss drugs
- Sweden’s startups will raise $5 billion in 2026. Our secret sauce is 150 years old
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- How the 2026 Milan-Cortina Winter Olympics Will Reshape Company Revenues and Stock Performance
- Can Hedge Funds Use ChatGPT? A Control Framework